Navigation Links
GeoPharma Announces Record Revenues in Third Quarter Results
Date:2/14/2008

LARGO, Fla., Feb. 14 /PRNewswire-FirstCall/ -- GeoPharma, Inc. (Nasdaq: GORX) announced record revenues of $18.2 million for the third quarter representing more than a 200% increase in sales sequentially, as it reported financial results for the three and nine month periods ending December 31, 2007.

"We are pleased to report greatly improved financial results for the third quarter of our 2008 fiscal year; it demonstrates the benefit of the earlier executed Dynamic Health Products acquisition and showcases significant progress in our efforts to achieve critical mass of over 100 million dollars in revenues for our 2009 fiscal year which ends in March of 2009," stated GeoPharma CEO Mihir Taneja. "Although we are pleased with our financial progress, the third quarter was full of challenges that weighed on our results, which provides us with further confidence that we will see continued strength in the fourth quarter and the foreseeable future."

Q3 Financial Summary

-- Total revenues for the third quarter ended December 31, 2007 were $18.2

million as compared to the second quarter continuing operation revenues

for the three months ended September 30, 2007 of $6.0 million, an

increase of 203%.

-- Total revenues for the nine months ended December 31, 2007 were $34

million, an increase of 116% over the six months ended September 30,

2007.

-- Gross Profits for the third quarter ended December 31, 2007 increased

200% to $3.6 million as compared to the continuing operations gross

profits for the second quarter ended September 30, 2007 of $1.2

million.

-- Net loss for the December quarter 2007 was $(1.675) million as compared

to the September 2007 net loss of $(1.9) million. Net loss per share

for the December quarter 2007 was $(0.12) as compared to the September

2007 quarter net loss of $(0.16).

-- Selling, general and adm
'/>"/>

SOURCE GeoPharma, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6

Related biology technology :

1. GeoPharma Announces Third Quarter Conference Call
2. GeoPharma, Inc. Receives FDA Approval to Manufacture and Distribute Carprofen
3. Angiotech announces results for the fourth quarter ended December 31, 2007
4. Cell Therapeutics, Inc. (CTI) Announces Cancellation of Approximately $9.1 Million of Existing Notes due 2008
5. Warner Chilcott Announces Earnings Release Date and Conference Call for Fourth Quarter and Full Year 2007 Financial Results
6. Jazz Pharmaceuticals, Inc. Announces Fourth Quarter and Full Year 2007 Financial Results
7. NightHawk Radiology Holdings, Inc. Announces Senior Executive Departures
8. VLST Corporation Announces Board and Executive Management Appointments
9. Advance Nanotech Announces Shareholder Proxy Vote Results
10. Cellegy Pharmaceuticals Announces Signing of Definitive Merger Agreement
11. Halogen Announces Record Year - Company Solidifies Leadership Position, Secures Strategic Wins Over Competition
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2013)... 2013  AMRI (NASDAQ: AMRI ) ... , site has received approval to expand ... to handle Schedule 2 and 2N controlled substances. ... Burlington,s physical security and quality ... (Logo: http://photos.prnewswire.com/prnh/20120229/NY61160LOGO ) With ...
(Date:6/18/2013)... -- Techne Corporation (NASDAQ: TECH ) (Techne) ... 100% ownership of Bionostics Holdings Limited and its ... global leader in the development, manufacture and distribution ... of in vitro diagnostic (IVD) devices ... and blood gas testing.  Biosnostics has strategic supply ...
(Date:6/18/2013)... DUBLIN , June 18, 2013 /PRNewswire/ ... http://www.researchandmarkets.com/research/4b8vj2/injectable_drug ) has announced the addition of ... Formulations [Liposomes, Microspheres, & Nanoparticles], Devices [Disposables ... Free & Auto Injectors] & Therapeutics [Diabetes ... report to their offering. ...
(Date:6/18/2013)... , June 18, 2013 /PRNewswire/ ... ( http://www.researchandmarkets.com/research/cmbgcv/north_american ) has announced the ... Nuclear Medicine/Radiopharmaceuticals & Stable Isotopes Market ... Therapy (I131, Y-90)], [Applications (Cancer/Oncology, Cardiac)] ... 2017" report to their offering. ...
Breaking Biology Technology:AMRI Burlington Receives DEA Approval to Handle Controlled Substances 2Techne Corporation Announces Acquisition Agreement 2Techne Corporation Announces Acquisition Agreement 3Techne Corporation Announces Acquisition Agreement 4Techne Corporation Announces Acquisition Agreement 5Injectable Drug Delivery Market by Formulations, Devices & Therapeutics - Global Forecasts to 2017 2Injectable Drug Delivery Market by Formulations, Devices & Therapeutics - Global Forecasts to 2017 3North American Nuclear Medicine/Radiopharmaceuticals & Stable Isotopes Market - Forecast to 2017 2North American Nuclear Medicine/Radiopharmaceuticals & Stable Isotopes Market - Forecast to 2017 3
... ... Fourth Committee on behalf of issues facing the Western Sahara. , ... New York, New York (PRWEB) October ... Assembly Fourth Committee on behalf of issues facing the Western Sahara., , , , ...
... Calif., Oct. 10 Nektar Therapeutics (Nasdaq: ... 2 clinical trial of oral NKTR-118 at the American ... in Phoenix, Arizona. NKTR-118, an oral peripherally-acting opioid ... clinical development for the treatment of opioid-induced constipation. ...
... Queen,s University Belfast are developing new sensors to detect chemical ... against the threat of terrorist attacks. The devices will ... scene to gather a sample which is then analysed by ... within seconds. This will allow better, faster decisions to be ...
Cached Biology Technology:Actress and Singer, Cynthia Basinet Petitions United Nations 2Topline Results from Phase 2 Clinical Trial of Oral NKTR-118 Presented at 20th American Academy of Pain Management Annual Clinical Meeting (AAPM) in Phoenix 2Topline Results from Phase 2 Clinical Trial of Oral NKTR-118 Presented at 20th American Academy of Pain Management Annual Clinical Meeting (AAPM) in Phoenix 3Topline Results from Phase 2 Clinical Trial of Oral NKTR-118 Presented at 20th American Academy of Pain Management Annual Clinical Meeting (AAPM) in Phoenix 4New technology detects chemical weapons in seconds 2
(Date:6/18/2013)... London (18 June 2013). A team of internationally recognized ... Dr Sarah Ellis from the University of Lincoln, U.K. ... Wisconsin, U.S.A. were invited by the International Society of ... Practitioners (AAFP) to compile guidelines for veterinarians, owners and ... environmental needs of the domestic cat. The new guidelines ...
(Date:6/17/2013)... An international team led by scientists at The ... and Albert Einstein College of Medicine of Yeshiva University ... attacks the tuberculosis (TB) bacterium in two different ways. ... one of the major global health crises of our ... said Peter G. Schultz, the Scripps Family Chair Professor ...
(Date:6/17/2013)... As mobile devices, smartphones and tablets ... grows exponentially, and biometric authentication offers that security, ... Reading Insider ( www.heavyreading.com/mobile-networks ), a subscription ... www.heavyreading.com ). Biometrics Offer Promise for ... authentication on smartphones, analyzing the most lucrative verticals ...
Breaking Biology News(10 mins):Feline behavior experts release guidelines to improve the welfare of cats 2New compound excels at killing persistent and drug-resistant tuberculosis 2New compound excels at killing persistent and drug-resistant tuberculosis 3New compound excels at killing persistent and drug-resistant tuberculosis 4Biometric Authentication Provides Better Mobile Device Security, Heavy Reading Finds 2Biometric Authentication Provides Better Mobile Device Security, Heavy Reading Finds 3
... soon be possible, thanks to a discovery made by a ... found a new stroke death channel ?the conduit through which ... the cell death that disables stroke victims. , The ... subject of an editorial in next month's issue of Nature ...
... can be effectively repaired by tissue engineering and ... research led by scientists at the University of ... cartilage implanted in injured and osteoarthritic human knees", ... 7) issue of Tissue Engineering, demonstrates that engineered ...
... MUHC have announced Quebec's first successful combined heart/liver transplant. ... from the Institut de cardiologie de Quebec (l'hôpital Laval) ... and liver during a 6-hour operation on April 14, ... procedure involved 15 physicians, surgeons and other health care ...
Cached Biology News:UBC researchers find stroke death channel 2MUHC announces a transplant first in Quebec 2
... genome-wide microRNA expression profiling and built ... microfluidic on-chip synthesis platform. These microarrays ... comprehensive microRNA Expression Profiling Service. ... microRNA Microarray contains all known mammal ...
... Proteolytic degradation is critical to the ... and regulatory proteins as important and ... metabolism, heat shock and stress response, ... receptors and ion channels, cell cycle ...
... Molecular Imaging Systems offer an optional ... science researchers to conveniently capture and ... organs and whole animals with molecular ... of molecular signals that are generated ...
... Features hardwall acrylic panels ... frame to form a free-standing ... to Class 10/ISO 3. Optional ... and ionizers are configured to ...
Biology Products: